514 related articles for article (PubMed ID: 11689684)
1. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
Lorincz MC; Schübeler D; Groudine M
Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
[TBL] [Abstract][Full Text] [Related]
2. Dynamic analysis of proviral induction and De Novo methylation: implications for a histone deacetylase-independent, methylation density-dependent mechanism of transcriptional repression.
Lorincz MC; Schübeler D; Goeke SC; Walters M; Groudine M; Martin DI
Mol Cell Biol; 2000 Feb; 20(3):842-50. PubMed ID: 10629041
[TBL] [Abstract][Full Text] [Related]
3. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
[TBL] [Abstract][Full Text] [Related]
4. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
5. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
Nan X; Ng HH; Johnson CA; Laherty CD; Turner BM; Eisenman RN; Bird A
Nature; 1998 May; 393(6683):386-9. PubMed ID: 9620804
[TBL] [Abstract][Full Text] [Related]
7. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
Fuks F; Hurd PJ; Wolf D; Nan X; Bird AP; Kouzarides T
J Biol Chem; 2003 Feb; 278(6):4035-40. PubMed ID: 12427740
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
Majumder S; Kutay H; Datta J; Summers D; Jacob ST; Ghoshal K
J Cell Biochem; 2006 Apr; 97(6):1300-16. PubMed ID: 16329111
[TBL] [Abstract][Full Text] [Related]
9. Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications.
Yao S; Sukonnik T; Kean T; Bharadwaj RR; Pasceri P; Ellis J
Mol Ther; 2004 Jul; 10(1):27-36. PubMed ID: 15233939
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
11. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation.
Schübeler D; Lorincz MC; Cimbora DM; Telling A; Feng YQ; Bouhassira EE; Groudine M
Mol Cell Biol; 2000 Dec; 20(24):9103-12. PubMed ID: 11094062
[TBL] [Abstract][Full Text] [Related]
12. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications.
Xiong Y; Dowdy SC; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2006 Oct; 103(1):321-8. PubMed ID: 16701802
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
14. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
15. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
Jones PL; Veenstra GJ; Wade PA; Vermaak D; Kass SU; Landsberger N; Strouboulis J; Wolffe AP
Nat Genet; 1998 Jun; 19(2):187-91. PubMed ID: 9620779
[TBL] [Abstract][Full Text] [Related]
16. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
Drewell RA; Goddard CJ; Thomas JO; Surani MA
Nucleic Acids Res; 2002 Mar; 30(5):1139-44. PubMed ID: 11861904
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
18. In vivo repression of an erythroid-specific gene by distinct corepressor complexes.
Rietveld LE; Caldenhoven E; Stunnenberg HG
EMBO J; 2002 Mar; 21(6):1389-97. PubMed ID: 11889044
[TBL] [Abstract][Full Text] [Related]
19. Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencing.
Leung DC; Dong KB; Maksakova IA; Goyal P; Appanah R; Lee S; Tachibana M; Shinkai Y; Lehnertz B; Mager DL; Rossi F; Lorincz MC
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5718-23. PubMed ID: 21427230
[TBL] [Abstract][Full Text] [Related]
20. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]